Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DAITO KOUN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Oct-Dec Ordinary Profit Increases by 25%
9367 DAITO KOUN CO.,LTD. 【J-GAAP】
Earnings ReportDAITO KOUN CO.,LTD. <9367> [TSE Std] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 6.7% from the same period last year, reaching 775 million yen. The progress rate toward the full-year plan of 850 million yen was 91.2%, also surpassing the five-year average of 86.6%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 7.1% from the same period last year, reaching 75 million yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 24.9% from the same period last year, reaching 336 million yen. The operating profit margin improved from 4.8% in the same period last year to 6.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 13,160 | 898 | 1,045 | 702 | 81.8 | 88.7 | Feb 9, 2023 | J-GAAP |
Apr - Dec, 2023 | 12,345 | 589 | 726 | 485 | 56.4 | 91.2 | Feb 9, 2024 | J-GAAP |
Apr - Dec, 2024 | 12,880 | 648 | 775 | 525 | 60.9 | 91.2 | Feb 10, 2025 | J-GAAP |
YoY | +4.3% | +10.0% | +6.7% | +8.2% | +8.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 7,827 | 248 | 339 | 255 | 29.7 | 11 | May 14, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 8,589 | 378 | 411 | 279 | 32.3 | 12 | Nov 12, 2024 | J-GAAP |
YoY | +9.7% | +52.4% | +21.2% | +9.4% | +9.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 17,130 | 1,038 | 1,178 | 783 | 91.2 | 20 | May 12, 2023 | J-GAAP |
Mar, 2024 | 16,051 | 641 | 796 | 534 | 62.1 | 21 | May 14, 2024 | J-GAAP |
Mar, 2025 Guidance | 17,000 | 750 | 850 | 580 | 67.2 | 24 | May 14, 2024 | J-GAAP |
YoY | +5.9% | +17.0% | +6.8% | +8.6% | +8.2% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 4,121 | 196 | 269 | 206 | 24.0 | 4.8 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 3,706 | 52 | 70 | 49 | 5.7 | 1.4 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 4,250 | 178 | 217 | 140 | 16.3 | 4.2 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 4,161 | 194 | 222 | 161 | 18.7 | 4.7 | Nov 12, 2024 | J-GAAP |
Oct - Dec, 2024 | 4,469 | 276 | 336 | 224 | 26.0 | 6.2 | Feb 10, 2025 | J-GAAP |
YoY | +8.4% | +40.8% | +24.9% | +8.7% | +8.5% |
Related Articles
Monogatari, First Half Ordinary Profit Increases by 0.4%
SINANEN HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 9.6 times
MARUYAMA MFG, Oct-Dec (1Q) Ordinary Profit Loss Widens
SoftBank Corp, Apr-Dec (Cumulative 3Q) Net Income Increases by 7%
NITTO KOGYO, Oct-Dec (3Q) Ordinary Profit Increases by 17%
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year